LA-CAB/RPVLong-acting injectable antiretroviral therapycabotegravir/rilpivirine
…g hours were considered adequate for 85%.Treatment Convenience: LA-CAB/RPV was perceived as more convenient than daily oral ART by 95% of …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 181–240 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
PPCI7ICI therapy7Gene therapy7Neuromodulation7cardiac surgery7Antiviral treatment7Transarterial embolization7Endocrine therapy7Erector Spinae Plane Block7Stent-assisted coiling7anticoagulation therapy7cancer treatments7placebo7Anticoagulant therapy7Cancer therapy7Liver transplant7MT7Speech therapy7biological therapy7intravenous fluids7standard care7Chimeric antigen receptor (CAR)-T cell therapy7Hyperthermic intraperitoneal chemotherapy7Neoadjuvant chemoimmunotherapy7Pulmonary Vein Isolation7Steroid therapy7anti-tubercular therapy7extracorporeal membrane oxygenation7insulin treatment7vaccines7SABR6ESD6SOC6TAE6ADT6AVR6Hyperbaric oxygen therapy6LT6Embolization6Fecal Microbiota Transplantation6Coil embolization6monotherapy6gluten-free diet6Photodynamic therapy6lung transplantation6Immunosuppressive treatment6Oncolytic virotherapy6SBRT6euthanasia6Pharmacological therapy6Stereotactic body radiotherapy6Thrombolytic therapy6VSS6hormonal therapy6hormone therapy6sedation6systemic therapies6Adoptive Cell Therapies6Antimicrobial treatment6Aortic valve replacement6
Articles mentioning treatments
7,227 articles · page 26 of 603EUS-CGLAMSJoanna Briggs InstitutePFCs
…5% to 100%, respectively, with pooled recurrence ≈6%.Conclusion EUS-CG is a safe, feasible and highly effective treatment for PFCs in …
Parathyroidectomynon-surgical managementPrimary hyperparathyroidismPHPTCochrane Central Register of Controlled Trialsrenal stonesEMBASECKD
…ses the risk of renal stones and progressive renal dysfunction. Parathyroidectomy is recommended for patients with renal involvement, yet whether…
CPAPNIVBiPAPneurodisabilityPediatr. Pulmonol. 2021remote monitoring
…ely using a telemonitoring-compatible device. Of these, 13 used CPAP and 7 were on BiPAP. Median NIV usage was 76/90 days, and media…
PRTiodine-125 plaque radiotherapyBeijing Tongren Hospitaluveal melanoma
…egrouped the patients who underwent secondary enucleation after PRT. These differences in histopathology may represent tissue effec…
chemotherapychemoimmunotherapypaclitaxelcamrelizumabcisplatinChiCTR2000040034ESCC
…d with chemotherapy has demonstrated higher response rates than chemotherapy alone in resectable esophageal squamous cell carcinoma (ESCC). …
CBTTAUcognitive–behavioural therapyChronic non-cancer pain
…ical magnitude of this effect? And, in a nutshell, should I use CBT instead of TAU to tackle pain in adults with chronic pain?…
Effect of deep brain stimulation on patients with Parkinson’s disease with mild cognitive impairment
Deep brain stimulationDBSParkinson’s diseasePD-MCIPDDPDEmbasePubMed
…rkinson’s disease (PD), often progressing to PD dementia (PDD). Deep brain stimulation (DBS) is an established treatment for PD motor symptoms, but it…
IPPdiabeteshypercholesterolaemiahypertensionchronic non-communicable diseases (cNCDs)IPP
…e evaluated the evidence of independent pharmacist prescribing (IPP) in the treatment of metabolic targets associated with chronic …
PrEPPre-exposure prophylaxisPrEP-relatedtenofovir disoproxilemtricitabineHIVNational Health ServiceNHSItalian Medicines Agency
…analysis, of whom three women and 124 men. Among them, 76% used PrEP on-demand, and 22% on a daily regime. At the time of the most r…
PrEPdiabetesgonorrhoeasyphilisdyslipidaemiaHIVhypertensionchlamydianephropathyliver disease
…d diabetes (4.26%). 12% percent had nephropathy before starting PrEP. Serum creatinine (0.95 ± 0.46 g/dL) and phosphorus (3.43 ± 1.7…